FirstPurpose Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$915K Sell
11,113
-32
-0.3% -$2.73K 0.33% 56
2023
Q4
$918K Buy
11,145
+628
+6% +$47.9K 0.35% 50
2023
Q3
$824K Buy
10,517
+989
+10% +$82.8K 0.36% 51
2023
Q2
$839K Buy
9,528
+1,037
+12% +$89.3K 0.36% 50
2023
Q1
$685K Buy
8,491
+1,901
+29% +$155K 0.34% 58
2022
Q4
$512K Buy
6,590
+1,603
+32% +$130K 0.29% 66
2022
Q3
$403K Buy
4,987
+672
+16% +$60.4K 0.27% 69
2022
Q2
$387K Buy
4,315
+482
+13% +$48.8K 0.26% 70
2022
Q1
$425K Buy
3,833
+848
+28% +$89.6K 0.33% 65
2021
Q4
$309K Buy
+2,985
New +$346K 0.19% 93

Other funds holding MDT

FirstPurpose Wealth's MDT Position: Q1 2024 in Review

FirstPurpose Wealth reduced its Medtronic (MDT) stake by 0.29% in Q1 2024, selling an estimated $2.73K and leaving 11,113 shares worth $915K. The position accounts for 0.33% of the portfolio, ranked #56.

FirstPurpose Wealth first reported a position in MDT in Q4 2021 and has held it in 10 quarters since. The position peaked at $918K in Q4 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • FirstPurpose Wealth held 11,113 shares of Medtronic worth $915K as of Q1 2024.
  • FirstPurpose Wealth sold 32 Medtronic shares in Q1 2024, an estimated $2.73K.
  • Medtronic made up 0.33% of FirstPurpose Wealth's portfolio in Q1 2024, its #56 holding.
  • FirstPurpose Wealth first reported a position in Medtronic in Q4 2021 and has held it in 10 quarters since.
  • FirstPurpose Wealth's Medtronic position peaked at $918K in Q4 2023.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on FirstPurpose Wealth's 13F filing for Q1 2024, filed 23 Apr 2024.